Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia

J Med Virol. 2021 Feb;93(2):686-688. doi: 10.1002/jmv.26494. Epub 2020 Oct 5.

Authors

Giuseppe Greco¹, Diego Ripamonti¹, Francesca Binda¹, Fabrizio Fabretti², Lorenzo Grazioli², Marco Rizzi¹

Affiliations

¹ Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
² Anesthesiology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.

PMID: 32897539
DOI: 10.1002/jmv.26494

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized / administration & dosage*
Antibodies, Monoclonal, Humanized / therapeutic use*
COVID-19 / complications*
COVID-19 / therapy*
Female
Humans
Injections, Subcutaneous
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
tocilizumab